| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Cellebrite DI Ltd
Cellebrite DI Ltd
NASDAQ:CLBT
Cellebrite DI Ltd
Other Long-Term Assets
Cellebrite DI Ltd
Other Long-Term Assets Peer Comparison
WKME
SPNS
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cellebrite DI Ltd
NASDAQ:CLBT
|
Other Long-Term Assets
$14.4m
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
R
|
Riskified Ltd
NYSE:RSKD
|
Other Long-Term Assets
$20.8m
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Walkme Ltd
NASDAQ:WKME
|
Other Long-Term Assets
$30.6m
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sapiens International Corporation NV
NASDAQ:SPNS
|
Other Long-Term Assets
$19.7m
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
21%
|
|
N
|
Nice Ltd
TASE:NICE
|
Other Long-Term Assets
$398.3m
|
CAGR 3-Years
29%
|
CAGR 5-Years
36%
|
CAGR 10-Years
28%
|
|
H
|
Hilan Ltd
TASE:HLAN
|
Other Long-Term Assets
₪21.2m
|
CAGR 3-Years
17%
|
CAGR 5-Years
37%
|
CAGR 10-Years
39%
|
See Also
What is Cellebrite DI Ltd's Other Long-Term Assets?
Other Long-Term Assets
14.4m
USD
Based on the financial report for Dec 31, 2023, Cellebrite DI Ltd's Other Long-Term Assets amounts to 14.4m USD.
What is Cellebrite DI Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 3Y
22%
Over the last year, the Other Long-Term Assets growth was 1%. The average annual Other Long-Term Assets growth rates for Cellebrite DI Ltd have been 22% over the past three years .
You don't have any saved screeners yet
